Amyotrophic Lateral Sclerosis (ALS) Research, Treatment, and Assistance Act of 1997
Amyotrophic Lateral Sclerosis (ALS) Research, Treatment, and Assistance Act of 1997 - Amends title II (Old Age, Survivors and Disability Insurance) of the Social Security Act (SSA) to provide for a waiver of the 24-month waiting period for Medicare coverage for individuals disabled by amyotrophic lateral sclerosis, also known as ALS or Lou Gehrig's Disease.
Amends SSA title XVIII (Medicare) to provide for Medicare coverage of any drug approved by the Food and Drug Administration for use in the treatment or alleviation of ALS-related symptoms.
Authorizes appropriations, in addition to any already available, for ALS research through the National Institutes of Health.
Referred to the Subcommittee on Health and Environment, for a period to be subsequently determined by the Chairman.